Advertisement

Common Dermatological Conditions

  • Mercedes E. Gonzalez
Chapter

Abstract

Abnormalities of the skin including birthmarks and rashes in the newborn are often a source of concern for parents. However, most of these abnormalities are benign and self-limited. A birthmark is a congenital irregularity on the skin which is present at birth or appears shortly after birth, usually in the first month. They can occur anywhere on the body. Skin integrity including texture, hydration, and edema is part of any complete physical examination. Are these skin lesions primary or secondary? Are they static or evolving? This chapter will discuss the most common birthmarks and skin eruptions seen in the newborn and review diagnosis and management in the context of clinical cases.

Keywords

Erythema toxicum neonatorum Transient neonatal pustular melanosis Congenital cutaneous candidiasis Miliaria rubra Aplasia cutis Nevus sebaceous Nevus simplex Infantile hemangioma Port-wine stain Congenital melanocytic nevi 

References

  1. 1.
    Rayala BZ, Morrell DS. Common skin conditions in children: neonatal skin lesions. FP Essent. 2017;453:11–7.PubMedGoogle Scholar
  2. 2.
    Hussain S, Venepally M, Treat JR. Vesicles and pustules in the neonate. Semin Perinatol. 2013;37(1):8–15.  https://doi.org/10.1053/j.semperi.2012.11.005.CrossRefPubMedGoogle Scholar
  3. 3.
    Oza V, Asch S, Mathes EF. Three day old with palmar pustules. JAMA Pediatr. 2016;170(2):171–2.  https://doi.org/10.1001/jamapediatrics.2015.1996.CrossRefPubMedGoogle Scholar
  4. 4.
    Darmstadt GL, Dinulos JG, Miller Z. Congenital cutaneous candidiasis: clinical presentation, pathogenesis and management guidelines. Pediatrics. 2000;105(2):438–44.CrossRefGoogle Scholar
  5. 5.
    Kaufman DA, Coggins SA, ZanelliJörn-Hendrik Weitkamp SA. Congenital cutaneous candidiasis: prompt systemic treatment is associated with improved outcomes in neonates. Clin Infect Dis. 2017;64(10):1387–95.  https://doi.org/10.1093/cid/cix119.CrossRefPubMedGoogle Scholar
  6. 6.
    Patel DP, Castelo-Soccio L, Yan AC. Aplasia cutis congenita: evaluation of signs suggesting extracutaneous involvement. Pediatr Dermatol. 2017:27.  https://doi.org/10.1111/pde.13340.CrossRefGoogle Scholar
  7. 7.
    Idriss MH, Elston DM. Secondary neoplasms associated with nevus sebaceous of Jadassohn: a study of 707 cases. J Am Acad Dermatol. 2014;70(2):332–7.CrossRefGoogle Scholar
  8. 8.
    Krengel S, Scope A, Dusza SW, et al. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68:441–51.CrossRefGoogle Scholar
  9. 9.
    Schaffer JV. Update on melanocytic nevi in children. Clin Dermatol. 2015;33(3):368–86.CrossRefGoogle Scholar
  10. 10.
    Kinsler VA, O’Hare P, Bulstrode N, et al. Melanoma in congenital melanocytic naevi. Br J Dermatol. 2017;176(5):1131–43.CrossRefGoogle Scholar
  11. 11.
    Rosenblatt A, Mathes EF, Rosbe KW. Infantile hemangiomas: from pathogenesis to clinical features. Res Rep Neonatol. 2012;2:55–65.Google Scholar
  12. 12.
    Piram M, Hadj-Rabia S, Boccara O, et al. Beard infantile hemangioma and subglottic involvement: are median pattern and telangiectatic aspect the clue? J Eur Acad Dermatol Venereol. 2016;30(12):2056–9.CrossRefGoogle Scholar
  13. 13.
    Rialon KL, Murillo R, Fevurly RD, et al. Impact of screening for hepatic hemangiomas in patients with multiple cutaneous infantile hemangiomas. Pediatr Dermatol. 2015;32(6):808–12.CrossRefGoogle Scholar
  14. 14.
    Horii KA, Drolet BA, Frieden IJ, et al. Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol. 2011;28(3):245–53.CrossRefGoogle Scholar
  15. 15.
    Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–46.CrossRefGoogle Scholar
  16. 16.
    Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128–40. https://www-ncbi-nlm-nih-gov.access.library.miami.edu/pubmed/23266923.CrossRefGoogle Scholar
  17. 17.
    Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, et al. Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics. 2016;138(4):e20160353.CrossRefGoogle Scholar
  18. 18.
    Martin K, Blei F, Chamlin SL, et al. Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers. Pediatr Dermatol. 2013;30(1):155–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Mercedes E. Gonzalez
    • 1
    • 2
  1. 1.Pediatric Dermatology of Miami, Department of DermatologyUniversity of Miami Miller School of MedicineMiamiUSA
  2. 2.Herbert Wertheim College of MedicineFlorida International UniversityMiamiUSA

Personalised recommendations